Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Baum

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
Blood|June 21, 2008
Resistance of mature T cells to oncogene transformationSebastian Newrzela, Kerstin Cornils, Zhixiong Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 18, 2014
Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cellsJohannes Kuehle, Soeren Turan, Tobias Cantz, et al.
Biomaterials|February 18, 2014
All-in-One inducible lentiviral vector systems based on drug controlled FLP recombinaseTobias Maetzig, Johannes Kuehle, Adrian Schwarzer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 13, 2009
Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectorsUte Modlich, Susana Navarro, Daniela Zychlinski, et al.
Blood|October 13, 2011
Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemiaPekka Jaako, Johan Flygare, Karin Olsson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2012
Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicingKerstin B Kaufmann, Christian Brendel, Julia D Suerth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2012
Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicityJulia D Suerth, Tobias Maetzig, Martijn H Brugman, et al.
Blood|March 10, 2009
Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cellsMichael D Milsom, Bernhard Schiedlmeier, Jeff Bailey, et al.
Molecular Therapy. Nucleic Acids|October 15, 2018
Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene KnockoutYvonne Knopp, Franziska K Geis, Dirk Heckl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 19, 2009
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and designGiulietta Maruggi, Simona Porcellini, Giulia Facchini, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Blood|June 21, 2008
Resistance of mature T cells to oncogene transformationSebastian Newrzela, Kerstin Cornils, Zhixiong Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 18, 2014
Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cellsJohannes Kuehle, Soeren Turan, Tobias Cantz, et al.
Biomaterials|February 18, 2014
All-in-One inducible lentiviral vector systems based on drug controlled FLP recombinaseTobias Maetzig, Johannes Kuehle, Adrian Schwarzer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 13, 2009
Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectorsUte Modlich, Susana Navarro, Daniela Zychlinski, et al.
Blood|October 13, 2011
Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemiaPekka Jaako, Johan Flygare, Karin Olsson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2012
Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicingKerstin B Kaufmann, Christian Brendel, Julia D Suerth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2012
Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicityJulia D Suerth, Tobias Maetzig, Martijn H Brugman, et al.
Blood|March 10, 2009
Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cellsMichael D Milsom, Bernhard Schiedlmeier, Jeff Bailey, et al.
Molecular Therapy. Nucleic Acids|October 15, 2018
Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene KnockoutYvonne Knopp, Franziska K Geis, Dirk Heckl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 19, 2009
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and designGiulietta Maruggi, Simona Porcellini, Giulia Facchini, et al.
Pageof 15